Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for patients with prostate cancer.

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 ...

Market OverviewThe global transrectal ultrasound (TRUS) market is experiencing consistent expansion and is projected to grow at a compound annual growth rate of around 6% during the forecast period.

Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ReSTART pivotal skin cancer trial as well as trials in cance ...

Expecting very active 2026 from a clinical perspective, including significant patient accrual completions and subsequent data readouts from ...

For many men, a prostate cancer diagnosis raises an immediate question: what are my treatment options and how will they affect my life?By Professor ...

The American University of Beirut Medical Center (AUBMC) continues to advance its mission of excellence in healthcare and ...

Proton therapy, a highly advanced form of radiation therapy, uses charged proton particles to destroy cancer cells. It is now ...

The Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) has made a major leap in cancer care, becoming the first public hospital in the region to offer Lutetium-177 PSMA therapy.

Mercy Medical Center is offering a new, noninvasive treatment option for men with localized prostate cancer using high-intensity focused ultrasound, also known ...

Alpha Tau Medical targets major 2026 catalysts as Alpha DaRT gains momentum; key pancreatic & GBM readouts ahead. Read the full analysis here of DRTS stock.